NL-OMON44377已完成不适用
Perioperative Management of Patients who are Receiving a Novel Oral Anticoagulant (Dabigatran, Rivaroxaban or Apixaban) and Require an Elective Surgery or Medical Procedure: A Prospective Cohort Study (PAUSE)* - PAUSE study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- age > 18 years
- •- receiving a NOAC (dabigatran or rivaroxaban or apixaban) for stroke prevention for Atrial Fibrillation (SPAF)
- •- ability to adhere to the NOAC discontinuation protocol
- •- patient will be undergoing any elective surgical procedure or intervention
排除标准
- •- CrCl <30 mL/min for dabigatran- and rivaroxaban-treated patients (<25 mL/min for apixaban-treated patients) as estimated by Cockroft-Gault formula
- •- Cognitive impairment or psychiatric illness that precludes collection of follow-up data
- •- Inability or unwillingness to provide informed consent
- •- Previous participation in this study having had a surgery/procedure performed
研究者
相似试验
进行中（未招募）
1 期
uwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)Haemophilia ACTIS2022-502060-21-00Octapharma AG50
已完成
2 期
ESSENSE protocol for peri-operative patients management; a multi-center prospective clinical trialJPRN-UMIN000014175Japanese Society for Surgical metabolism and nutrition120
尚未招募
不适用
Course of patients with pre-existing brain or spine disease undergoing non-neurological surgery: A prospective observational studyCTRI/2021/04/033030AIIMS JODHPUR
已完成
不适用
Monitoring the effects of Antihypertensives(ACE Inhibitors / ARBS)in patients undergoing surgeyCTRI/2020/06/025892Kasturba Medical College Manipal60
尚未招募
Unknown
To evaluate critical events occurring before, during and after surgery in patients receiving anaesthesia undergoing major surgeryCTRI/2023/08/056472Tata Memorial Hospital